This study tests a Vaginal Cooling Device (VCD) to treat Vulvovaginal Candidiasis (VVC), a common yeast infection. The study looks at how well the device works and is safe. It checks the speed of symptom relief, like itching or pain, and the quality of life during treatment. Women aged 22-49, who have a smartphone and can use an app called ValidCare, may join. They must have a recent Pap test and a confirmed VVC diagnosis. Participants should avoid sexual activity and can use menstrual products during the study.
- Participation requires avoiding sexual activity and keeping to the study protocol for 28 days.
- Participants must not use certain medications like antibiotics and antifungals 14 days before the study.
- No compensation details are mentioned, but the study assesses the device's safety and effectiveness.